Practice Alert Podcast

Beyond the headlines: A closer look at the USPSTF draft recs on aspirin

J Fam Pract. 2021 November;70(9):audio
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

The US Preventive Services Task Force recently made big news with its draft update that recommends against the initiation of low-dose aspirin for primary prevention of cardiovascular disease in patients ≥ 60 years. But there are other aspects of the draft that family physicians need to know about. This month, Dr. Campos-Outcalt provides a closer look at the draft recommendations and discusses which patients should initiate—or continue taking—daily low-dose aspirin.

 

REFERENCES

  1. US Preventive Services Task Force. Aspirin use to prevent cardiovascular disease: preventive medication. Published October 12, 2021. Accessed October 25, 2021. www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
  2. National Center for Health Statistics. Figure 4. Number of deaths, percentage of total deaths, and age-adjusted death rates for the 10 leading causes of death in 2019: United States, 2018 and 2019. In: Data Brief 395: Mortality in the United States 2019. Published December 2020. Accessed October 25, 2021. www.cdc.gov/nchs/data/databriefs/db395-tables-508.pdf
  3. American College of Cardiology/American Heart Association. Heart risk calculator. Updated November 12, 2017. Accessed October 25, 2021. www.cvriskcalculator.com/

Next Article:

Social determinants of health may drive CVD risk in Black Americans